Aveanna Healthcare Holdings (AVAH) is back on investor radars after recent research coverage highlighted meaningful upward revisions to full year earnings estimates and an improved Zacks Rank of #2, which signals stronger analyst conviction.

The recent earnings upgrades and momentum signals are coming on top of a strong run, with Aveanna Healthcare Holdings posting a 90 day share price return of 28.14% and a 1 year total shareholder return of 74.28%. The 3 year total shareholder return is very large at nearly 4x, even though the 5 year total shareholder return is still down 31.53%. This suggests renewed momentum after a weaker earlier period.

If Aveanna’s recent move has caught your attention, this can be a good moment to look across other healthcare focused opportunities and see how they compare using the 38 healthcare AI stocks

With analyst targets sitting above the current US$8.47 share price and one intrinsic value estimate implying further upside, Aveanna Healthcare Holdings now sits in an interesting spot. Is there still underappreciated value here, or is the market already pricing in future growth?

Most Popular Narrative: 14.9% Undervalued

The most followed narrative currently places Aveanna Healthcare Holdings' fair value at $9.95 per share, above the recent $8.47 close. On those assumptions, this frames the stock as modestly undervalued.

Successful execution of the preferred payer strategy, including a rapid increase in preferred payer agreements in all segments and legislative progress on rate enhancements, supports higher reimbursement rates, better operating leverage, and improved net margins into 2025 and beyond. Ongoing investment in operational efficiencies, such as modernizing digital workflows, centralized billing, and preferred payer alignment, is expected to drive further margin expansion and increase free cash flow, strengthening liquidity and enabling future M&A led growth.

Curious what kind of revenue path, margin reset, and future earnings multiple are built into that $9.95 figure? The narrative leans on specific growth, profitability, and valuation assumptions that may surprise you when viewed alongside Aveanna Healthcare Holdings' recent results.

Result: Fair Value of $9.95 (UNDERVALUED)

However, Aveanna Healthcare Holdings still faces meaningful risks, including high variable rate debt of about US$1.47b, and heavy reliance on Medicaid and Medicare reimbursement policies.

Next Steps

With both risks and rewards in play for Aveanna Healthcare Holdings, do the current narratives feel balanced enough to you, or overly optimistic? Take a few minutes to review the underlying data, compare it with your expectations, and then weigh the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Aveanna Healthcare Holdings?

Do not stop at Aveanna Healthcare Holdings. Use this momentum to scan for other stocks that fit your style before the next wave of opportunities moves without you.

• Target income and stability by reviewing companies that stand out as potential income anchors using the 7 dividend fortresses.
• Look for stocks that the market may be overlooking right now through the screener containing 18 high quality undiscovered gems.
• Prioritize resilience by filtering for businesses with stronger balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.